These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1864717)

  • 41. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 42. [Corpus cavernosum autoinjection therapy in erectile dysfunction?].
    Jung A; Schill WB
    Med Monatsschr Pharm; 1994 Sep; 17(9):277-8. PubMed ID: 7968780
    [No Abstract]   [Full Text] [Related]  

  • 43. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R; Mohamed K; Akhras AA; Rashwan H
    Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction.
    Perimenis P; Athanasopoulos A; Geramoutsos I; Barbalias G
    Urol Int; 2001; 66(1):27-9. PubMed ID: 11150947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Priapism--a medical emergency.
    Nadig PW
    Tex Med; 1987 Sep; 83(9 Pt 1):6. PubMed ID: 3672394
    [No Abstract]   [Full Text] [Related]  

  • 48. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
    Zentgraf M; Baccouche M; Jünemann KP
    Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
    Bondil P; Rigot JM; Nguyen Qui JL; Mazeman E
    J Urol (Paris); 1987; 93(9-10):547-8. PubMed ID: 3443767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    J Urol (Paris); 1989; 95(1):33-9. PubMed ID: 2567318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A lethal complication of papaverine-induced priapism.
    Hashmat AI; Abrahams J; Fani K; Nostrand I
    J Urol; 1991 Jan; 145(1):146-7. PubMed ID: 1984077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A; Schramek P
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purulent corporeal cavernositis secondary to papaverine-induced priapism.
    Schwarzer JU; Hofmann R
    J Urol; 1991 Sep; 146(3):845-6. PubMed ID: 1875509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papaverine-induced priapism: case report.
    Liu LH; Liu LC; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Oct; 3(10):682-3. PubMed ID: 3482263
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.